Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Possinger

Showing results (71-80 of 166) with videos related to

Pageof 17
Sort By:
Oncology|November 6, 2002
Prediction of response to hormonal treatment in metastatic breast cancerP Schmid, M B Wischnewsky, O Sezer, et al.
British Journal of Cancer|January 5, 2012
Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancerC F Jehn, L Böning, H Kröning, et al.
Breast Cancer Research and Treatment|June 5, 2003
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitroH Liu, C Zang, M H Fenner, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 2, 2003
Differentiation of a pancreatic metastasis of a renal cell carcinoma from a primary pancreatic carcinoma by echo-enhanced power Doppler sonographyB Flath, S Rickes, M Schweigert, et al.
Fortschritte Der Medizin|July 30, 1987
[Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy]K Possinger, H Wagner, P Langecker, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
The comparability of quality of life scores. a multitrait multimethod analysis of the EORTC QLQ-C30, SF-36 and FLIC questionnairesS Kuenstner, C Langelotz, V Budach, et al.
Expert Opinion on Investigational Drugs|November 4, 2000
Novel approaches to the treatment of primary amyloidosisO Sezer, K Niemöller, C Jakob, et al.
Seminars in Oncology|April 1, 1991
Lonidamine in high-risk breast cancer patientsK Possinger, H Wagner, S Kovacs, et al.
Anticancer Research|November 20, 2001
Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancerR Kopp, S Classen, H Wolf, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 18, 2002
Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapyS Classen, R Kopp, K Possinger, et al.
Pageof 17

Showing results (71-80 of 166) with videos related to

Sort By:
Pageof 17
Oncology|November 6, 2002
Prediction of response to hormonal treatment in metastatic breast cancerP Schmid, M B Wischnewsky, O Sezer, et al.
British Journal of Cancer|January 5, 2012
Cetuximab-based therapy in elderly comorbid patients with metastatic colorectal cancerC F Jehn, L Böning, H Kröning, et al.
Breast Cancer Research and Treatment|June 5, 2003
PPARgamma ligands and ATRA inhibit the invasion of human breast cancer cells in vitroH Liu, C Zang, M H Fenner, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 2, 2003
Differentiation of a pancreatic metastasis of a renal cell carcinoma from a primary pancreatic carcinoma by echo-enhanced power Doppler sonographyB Flath, S Rickes, M Schweigert, et al.
Fortschritte Der Medizin|July 30, 1987
[Hormone therapy in metastasized breast cancer. Criteria for establishing indications and implementing high-dose medroxyprogesterone acetate therapy]K Possinger, H Wagner, P Langecker, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
The comparability of quality of life scores. a multitrait multimethod analysis of the EORTC QLQ-C30, SF-36 and FLIC questionnairesS Kuenstner, C Langelotz, V Budach, et al.
Expert Opinion on Investigational Drugs|November 4, 2000
Novel approaches to the treatment of primary amyloidosisO Sezer, K Niemöller, C Jakob, et al.
Seminars in Oncology|April 1, 1991
Lonidamine in high-risk breast cancer patientsK Possinger, H Wagner, S Kovacs, et al.
Anticancer Research|November 20, 2001
Predictive relevance of soluble CD44v6 serum levels for the responsiveness to second line hormone- or chemotherapy in patients with metastatic breast cancerR Kopp, S Classen, H Wolf, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|June 18, 2002
Clinical relevance of soluble c-erbB-2 for patients with metastatic breast cancer predicting the response to second-line hormone or chemotherapyS Classen, R Kopp, K Possinger, et al.
Pageof 17